sequence-selective DNA-binding payload-containing ADC (Pheon Therapeutics)

N/A

Report date: 2025/03/20 10:10:00

Base Information

Drug Namesequence-selective DNA-binding payload-containing ADC (Pheon Therapeutics)
Drug Alias Nameantibody-FGX-33-172 conjugate (Femtogenix/University of Southampton/King's College London)antibody-FGX-33-172 conjugate (Pheon Therapeutics)antibody-drug conjugate (Femtogenix/University of Southampton/King's College London)antibody-drug conjugate (Pheon Therapeutics)sequence-selective DNA-binding payload-containing ADC (Femtogenix/University of Southampton/King's College London)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Southampton
China Registration ClassN/A

Develop Information

Active CompaniesPheon Therapeutics LtdKing'S College LondonUniversity Of Southampton
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A